Mycobacterium aubagnense

Mycobacterium Aubagnense is a species of Mycobacterium that was first isolated in 2006. It is a non-tuberculous mycobacterium (NTM) and is part of the Mycobacterium avium complex (MAC).

Taxonomy

Mycobacterium Aubagnense is a member of the genus Mycobacterium, which is part of the family Mycobacteriaceae. The genus Mycobacterium contains over 150 species, many of which are pathogenic to humans and animals.

Discovery

Mycobacterium Aubagnense was first isolated in 2006 from a patient with pulmonary disease. The bacterium was named after the city of Aubagne in France, where the patient was treated.

Characteristics

Mycobacterium Aubagnense is a slow-growing, acid-fast bacterium. It is capable of surviving in a wide range of environments, including water and soil. The bacterium is resistant to many common antibiotics, making infections difficult to treat.

Pathogenicity

Mycobacterium Aubagnense can cause pulmonary disease, especially in individuals with compromised immune systems. Infections can also occur in healthy individuals, but this is less common. Symptoms of infection can include cough, fever, weight loss, and fatigue.

Treatment

Treatment of Mycobacterium Aubagnense infections typically involves a combination of antibiotics. However, the bacterium's resistance to many common antibiotics can make treatment challenging. In some cases, surgery may be required to remove infected tissue.

Epidemiology

Mycobacterium Aubagnense is found worldwide, but its prevalence is not well understood. It is thought to be more common in certain regions, such as Europe and North America.

See also

• Mycobacterium
• Mycobacterium avium complex
• Non-tuberculous mycobacteria

‎